June 2025
Data

Full report: Americans' opinions of psychedelics and support for policy reform

2025 national findings, plus a policy experiment showing how policy design shapes support and opposition.

March 2025
Data

What people think of when they hear the term "psychedelics"

Open-ended responses reveal which helpful and harmful mental models are most common.

November 2024
Data

Reflecting on Question 4: a post-election analysis of the results in Massachusetts

Why the measure fell 43–57: legalization framing, unfamiliar substances, and undecideds defaulting to "no."

October 2024
Data

How likely is Massachusetts to pass its psychedelics ballot measure?

Our pre-election analysis of the polls, past ballot measures, and prediction markets on Question 4.

August 2024
Data

Full report: How Americans think about psychedelics

Our first national deep-dive, with an executive summary and key strategy takeaways.

August 2024
Methods

How can 1,000 people tell us what the whole nation thinks?

Why a well-conducted survey of 1,000 people reliably captures the opinions of an entire country.

May 2024
Data

Most Americans overestimate the harms of psychedelics

Perceived harm of specific substances, benchmarked against tobacco and alcohol.

March 2024
Strategy

How to communicate uncertainties without losing credibility

When acknowledging uncertainty helps your message — and the situations where it backfires.

February 2024
Data

Support for MDMA treatment of PTSD far outnumbers opposition

Where the public stands on one of mental health's most promising recent advances.

January 2024
Data

Who is trusted (and who is not) for information about psychedelics?

The messengers who move undecided audiences — and the ones who backfire.